Olivier, T., & Prasad, V. (2022). Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later? Elsevier.
Chicago Style (17th ed.) CitationOlivier, Timothée, and Vinay Prasad. Neoadjuvant Checkpoint Inhibition in Non-small Cell Lung Cancer: Is Earlier Unquestionably Better than Later? Elsevier, 2022.
MLA (9th ed.) CitationOlivier, Timothée, and Vinay Prasad. Neoadjuvant Checkpoint Inhibition in Non-small Cell Lung Cancer: Is Earlier Unquestionably Better than Later? Elsevier, 2022.
Warning: These citations may not always be 100% accurate.